Status: current, Defined. Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3711986012 | Product containing sulfafurazole in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3711987015 | Sulfisoxazole-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3711988013 | Sulfafurazole-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sulfafurazole-containing product in oral dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some | ||
| Sulfafurazole-containing product in oral dose form | Is a | Sulfafurazole-containing product | true | Inferred relationship | Some | ||
| Sulfafurazole-containing product in oral dose form | Has active ingredient | Sulfisoxazole | true | Inferred relationship | Some | 1 | |
| Sulfafurazole-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Sulfafurazole-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sulfafurazole only product in oral dose form | Is a | True | Sulfafurazole-containing product in oral dose form | Inferred relationship | Some | |
| Sulphisoxazole acetyl 500mg/5mL suspension | Is a | False | Sulfafurazole-containing product in oral dose form | Inferred relationship | Some | |
| Phenazopyridine- and sulfafurazole-containing product | Is a | False | Sulfafurazole-containing product in oral dose form | Inferred relationship | Some | |
| Sulfafurazole 500 mg oral tablet | Is a | False | Sulfafurazole-containing product in oral dose form | Inferred relationship | Some | |
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Is a | False | Sulfafurazole-containing product in oral dose form | Inferred relationship | Some | |
| Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Is a | False | Sulfafurazole-containing product in oral dose form | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
FHIR